‘Covaxin efficacy 78%, works against variants’

Indigenous Covid-19 vaccine Covaxin has shown an overall interim clinical efficacy of 78% in fighting Covid-19. It has also shown 100% efficacy against severe Covid-19 disease, its developers Bharat Biotech and Indian Council of Medical Research (ICMR) said on Wednesday.
Indigenous Covid-19 vaccine Covaxin has shown an overall interim clinical efficacy of 78% in fighting Covid-19. It has also shown 100% efficacy against severe Covid-19 disease, its developers Bharat Biotech and Indian Council of Medical Research (ICMR) said on Wednesday.

from India News | Latest News Headlines & Live Updates from India - Times of India Indigenous Covid-19 vaccine Covaxin has shown an overall interim clinical efficacy of 78% in fighting Covid-19. It has also shown 100% efficacy against severe Covid-19 disease, its developers Bharat Biotech and Indian Council of Medical Research (ICMR) said on Wednesday.
via IFTTT